Search clinical trials for: hepatic artery infusion

Total 20157 results

Dana-Farber Cancer Institute

Recruiting

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Liver Cancer

United States
Minghui Zhang
Shanghai Public Health Clinical Center; First Hospital of Tsinghua University

Recruiting

Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non-small Cell Lung Cancer

China
Kenneth K. Tanabe, MD
National Cancer Institute (NCI)

Terminated

rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors

Liver Metastases | Primary Liver Cancers

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam
University Hospital, Linkoeping
Region Örebro County; Blekingesjukhuset, Karlskrona

Completed

Glutamate for Metabolic Intervention in Coronary Surgery (GLUTAMICS)

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Coronary Artery Bypass

Sweden
National Cancer Institute (NCI)

Active, not recruiting

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Combined Hepatocellular Carcinoma and Cholangiocarcinoma | Stage III Liver Cancer | Stage IV Liver Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Colorectal Cancer | Metastatic Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

Liver Cancer

United States
Hospices Civils de Lyon

Completed

Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma (SOMAPROTECT01)

Hepatocellular Carcinoma

France
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Unresectable Hepatocellular Carcinoma

United States
University of California, Los Angeles
W.L.Gore & Associates

Active, not recruiting

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents

Ascites | Hypertension, Portal

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Rectal Cancer | Colon Cancer | Hepatic Metastases

United States
Samsung Medical Center
Hanmi Pharmaceutical co., ltd.

Active, not recruiting

Usual Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque (Rosuzet-IVUS)

Coronary Artery Disease

Korea, Republic of
University of Florida
United States Department of Defense

Active, not recruiting

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR)

Coronary Artery Disease

United States, Puerto Rico
Memorial Sloan Kettering Cancer Center
Amgen

Active, not recruiting

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

Metastatic Colorectal Cancer

United States
Mitsubishi Tanabe Pharma GmbH

Completed

Safety of Argatroban Infusion in Conduction Disturbances (SAICoDis)

Stable Coronary Artery Disease (CAD) | Unstable Angina (Troponin Negative)

Germany
OHSU Knight Cancer Institute
Oregon Health and Science University

Active, not recruiting

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Liver and Intrahepatic Bile Duct Carcinoma | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Intrahepatic Cholangiocarcinoma

United States
Sun Yat-sen University
Second Affiliated Hospital of Guangzhou Medical University

Completed

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Carcinoma, Hepatocellular | Liver Neoplasms | Sintilimab | Portal Vein Tumor Thrombus

China
University Medical Center Groningen
Karolinska Institutet; National University Hospital, Singapore; Hospital Italiano... and other collaborators

Enrolling by invitation

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children (HEPATIC)

Pediatric ALL | Liver Transplant; Complications | Hepatic Artery Thrombosis | Hepatic Artery Stenosis

Netherlands
Second Affiliated Hospital of Guangzhou Medical...
First People's Hospital of Foshan; Huizhou Municipal Central Hospital; Zhongshan... and other collaborators

Completed

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Hepatocellular Carcinoma Non-resectable

China
Sun Yat-sen University

Completed

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Guangxi Medical University

Completed

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC (FRONT-1)

Liver Cancer

China
St. Louis University

Suspended

Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

Obesity | HCC | Body Weight | Hepatocellular Carcinoma | Hepatitis C | Weight Loss | Cirrhosis

United States
Fox Chase Cancer Center

Completed

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Advanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Adult Primary Hepatocellular Carcinoma | Metastatic Extrahepatic Bile Duct Cancer | Stage D Adult Primary Liver Cancer (BCLC)

United States
Peking University Cancer Hospital & Institute
Innovent Biologics (Suzhou) Co. Ltd.

Completed

HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma

Liver Metastases | Esophageal Squamous Cell Carcinoma | Hepatic Arterial Infusion Chemotherapy

China
Recep Tayyip Erdogan University

Completed

The Effect of Nitroglycerin Infusion Rate on Cerebral Rewarming During Hypothermic Coronary Artery Bypass Grafting (nitrotherm)

Coronary Artery Bypass | Cardiopulmonary Bypass

Turkey
University Hospital, Linkoeping
Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Region Örebro...

Completed

Glutamate for Metabolic Intervention in Coronary Surgery II (GLUTAMICSII)

Heart Failure | Postoperative Complications | Coronary Artery Bypass Surgery

Sweden
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.

Coronary Atherosclerosis and Other Heart Disease

Spain
Mayo Clinic

Withdrawn

Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
University of Copenhagen
Rigshospitalet, Denmark; Bispebjerg Hospital

Completed

Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis (GLUSENTIC)

Obesity | Type 1 Diabetes | Non-Alcoholic Fatty Liver Disease | Glucagon Resistance

Denmark
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Colorectal Cancer | Cholangiocarcinoma

United States
Xiang Guang-da

Completed

The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers

Diabetic Foot Ulcer

China
Scarlata, Simone, M.D.

Completed

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA

Lung Cancer | Endoscopy | Sedation Complication | Lung; Node

Italy
University of Iowa

Terminated

Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System (ATLAS)

Hypertension | Anxiety

United States
Sun Yat-sen University
Guangzhou No.12 People's Hospital; Kaiping Central Hospital

Withdrawn

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Hepatocellular Carcinoma

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); University of Medicine and Dentistry of New...

Active, not recruiting

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Intrahepatic Cholangiocarcinoma | Cholangiocellular Carcinoma | Peripheral Cholangiocarcinoma | Cholangiolar Carcinoma

United States
Peking University

Completed

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Advanced Biliary Tract Cancer

China
Sun Yat-sen University
First People's Hospital of Foshan; Guangzhou No.12 People's Hospital

Completed

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

HepatoCellular Carcinoma

China
University of Aarhus
Aarhus University Hospital; ADS AIPHIA Development Services AG

Terminated

Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide. (ULA04)

Cirrhosis, Liver | Ascites Hepatic

Denmark
Sun Yat-sen University
Innovent Biologics, Inc.

Active, not recruiting

HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC (HAICPD1-HCC)

Hepatocellular Carcinoma

China
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Hepatocellular Carcinoma | Liver Cancer

United States
Memorial Sloan Kettering Cancer Center
Wake Forest University

Completed

A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy

Hepatic Cancer

United States
William Beaumont Hospitals

Withdrawn

Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct (CRASCH-Liver)

Coronary Artery Disease | Acute Liver Failure | Liver Transplant

United States
Ochsner Health System
Bracco Corporate

Completed

3D PET Myocardial Blood Flow and Rb82 Infusion Profiles

Myocardial Infarction | Coronary Artery Disease | Cardiac Risk Factors | Normal Healthy Volunteers Without Chronic Medical Conditions

United States
Sorrento Therapeutics, Inc.

Terminated

Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases (AntiCEA_CART)

Metastatic Pancreatic Carcinoma

United States
University Hospital, Montpellier

Withdrawn

The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol (LIDA-ADJ)

Hepatocellular Carcinoma

France
University Hospital, Ghent

Completed

Effect of Norepinephrine Infusion on Hepatic Blood Flow During Goal-directed Haemodynamic Therapy.

General Anesthesia

Belgium
Wake Forest University Health Sciences

Completed

The Effects of Sedatives on Tobacco Use Disorder (SED-TUD)

Tobacco Use Disorder

United States
Endobar Solutions LLC
Na Homolce Hospital; OB KLINIKA a.s. Pod Krejcárkem 975 Praha 3 - Žižkov Tel... and other collaborators

Completed

The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial (LOSEIT)

Obesity, Morbid

Czechia

Search clinical trials for: hepatic artery infusion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations